CUE icon

Cue Biopharma

75 hedge funds and large institutions have $17.1M invested in Cue Biopharma in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

less ownership

Funds ownership:

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

45% less capital invested

Capital invested by funds: $31M → $17.1M (-$13.9M)

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$279K
Puts
$18K
Net Calls
Net Calls Change

Top Buyers

1 +$279K
2 +$274K
3 +$191K
4
Millennium Management
Millennium Management
New York
+$164K
5
BL
Bleichroeder LP
New York
+$132K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.55M
2
$2.98M
3
$2.52M
4
$938K
5
$613K
6
$611K
7
$593K
8
$435K
9
$403K
10
$344K
11
$330K
12
$330K
13
$319K
14
$314K
15
$301K
16
$266K
17
$241K
18
$220K
19
$191K
20
$150K
21
$148K
22
$122K
23
$116K
24
$103K
25
$103K